Venkys (India) Ltd

- Venky’s Limited does not plan any new external funding. - The capital expenditure for FY 2023-24, including a new animal health products project costing around INR 50 crores, will be funded entirely from internal generation. - No new debt or equity fundraising is being undertaken or planned according to the management’s statements during the call.

- For FY 2023-24, Venky’s Limited plans only routine capital expenditure. - One new project has been started in the Animal Health Products (AHP) segment. - The estimated cost of this new AHP project is around INR 50 crores. - Funding for this capex will come entirely from internal accruals; no external funding is planned. - No other diversification or new strategic investments have been announced at present.

- Poultry segment expected growth: 8% to 10% in volume terms for FY 2023-24. - Oilseed segment volume growth anticipated: 7% to 10%, though value growth is uncertain and market-driven. - Animal health products: Flat revenue last year due to restructuring; expected growth of 15% to 17% in FY 2023-24. - Broiler day-old chicks sales increased from 10.56 crores to 11.31 crores; commercial broiler bird volumes also rose slightly. - Quick Service Restaurants (QSR) sector expanding around 10% annually, with a shift from A-grade to B-grade cities, indicating growth potential. - Continuous new product launches planned, especially in processed food branded products, to expand market reach. - Capex of INR 50 crores for new animal health products project funded from internal accruals, supporting growth.

- Poultry segment volume growth expected at 8%-10%, but profitability remains volatile due to raw material (maize, soya) price fluctuations. Predicting steady profits is challenging. - Animal Health Products forecasted for 15%-17% growth in FY 2023-24, following a flat previous year due to restructuring. - Oilseed segment volume growth expected at 7%-10%, with margins around 3%, though value growth is unpredictable due to commodity price volatility. - The company is shifting focus from volatile poultry business to more stable, non-volatile segments like processed foods and AHP, aiming for steadier profits. - No major diversification planned; capital expenditure limited to the new animal health product project (~INR 50 crore) funded internally. - Overall, long-term growth is anticipated through expansion in branded products, processed foods, and QSR sourcing, with moderate volume growth across segments expected.

The transcript does not provide specific details on Venky's Limited's current or expected order book or pending orders. However, relevant information regarding business segments and growth expectations includes: - Venky’s supplies to around eight leading QSRs like KFC, Pizza Hut, Taco Bell, McDonald’s, indicating ongoing and stable demand. - The company is actively launching new processed food products, with some new products planned for the next quarter, suggesting healthy order inflow in that segment. - Growth outlook for poultry and oilseed volume is projected around 7% to 10% for FY ‘24. - Capital expenditure includes a new INR 50 crore project on animal health products, funded internally, signaling business expansion. - Pricing contracts with QSRs have been largely fixed for the next six months, implying secured orders in the near term. No explicit mention of exact orderbook or pending order values is available in the transcript.